Flash Glucose Monitoring: A Review of the Literature with a Special Focus on Type 1 Diabetes

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
hypoglycemia 9 endocrinologydiseases
type 1 diabetes mellitus 2 endocrinologydiseases
type 2 diabetes mellitus 1 endocrinologydiseases
Insulin 4 endocrinologydiseasesdrugs
diabetes mellitus 3 endocrinologydiseases
hyperglycemia 2 endocrinologydiseases

Graph of close proximity drug and disease terms (within 200 characters).

Note: If this graph is empty, then there are no terms that meet the proximity constraint.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Insulin 5708 hypoglycemia (such as during sleep). Furthermore, RT-iCGM can be associated with Continuous Subcutaneous Insulin Infusion (CSII), thus obtaining a Sensor-Augmented Pump (SAP), which in some cases includes algorithms
Insulin 22359 DisplayTrend ArrowsAlarms in Case of Hypoglycemia or HyperglycemiaMaximum Duration of SensorConnectivity to Insulin PumpAdjustment of the Insulin Dose Based on Sensor ResultsFGMInterstitialNoShowed on demandYesNo14 daysNoNoiCGMInterstitialYes,
Insulin 22389 Hypoglycemia or HyperglycemiaMaximum Duration of SensorConnectivity to Insulin PumpAdjustment of the Insulin Dose Based on Sensor ResultsFGMInterstitialNoShowed on demandYesNo14 daysNoNoiCGMInterstitialYes, daily
Insulin 22832 control.AuthorsPopulation (N, Age)DM TypePeriod AnalyzedEffect on HypoglycemiaEffect on HbA1cEffect on Daily Insulin Dose and Oral Hypoglycemic AgentsEffect on Time in RangeEffect on Glycemic VariabilitySystem UtilizationDover
Select Disease Character Offset Disease Term Instance
diabetes mellitus 726 (G.C.)Publication date (epub): 7/2018Publication date (collection): 8/2018AbstractIn people with type 1 diabetes mellitus (T1DM), obtaining good glycemic control is essential to reduce the risk of acute and chronic complications.
diabetes mellitus 2874 long-term microvascular and macrovascular complications [[1],[2]]. Therefore, in people with type 1 diabetes mellitus (T1DM), obtaining good glycemic control is essential to reduce the risk of acute and chronic complications
diabetes mellitus 14811 FGM use, in particular a reduction in hypoglycemia, have also been reported in patients with type 2 diabetes mellitus (T2DM) on intensive insulin therapy [[25],[26]]. Other authors [[27],[28]] showed improved metabolic
hyperglycemia 14233 in time spent in hypoglycemia. The intervention group also showed a reduction in the time spent in hyperglycemia , an increase in time within optimum glucose control and a reduction in glycemic variability. Furthermore,
hyperglycemia 17991 over FGM, such as better accuracy in the newest models of sensors, alarms in case of hypoglycemia or hyperglycemia and the possibility to connect to an insulin pump. For example, for individuals with severe hypoglycemia
hypoglycemia 5603 glycemic values are below or above a target range. This feature is especially useful to detect unsuspected hypoglycemia (such as during sleep). Furthermore, RT-iCGM can be associated with Continuous Subcutaneous Insulin
hypoglycemia 5991 reaches or is expected to reach a defined level. These options, which significantly help to prevent hypoglycemia , are only available with iCGM and are an important step towards automated closed-loop systems and an
hypoglycemia 13994 randomized controlled trial involving adult patients with well controlled T1DM showed a reduced time in hypoglycemia in the intervention group using FGM compared with that in the control group using capillary strips,
hypoglycemia 14151 with that in the control group using capillary strips, equating to a 38% decrease in time spent in hypoglycemia . The intervention group also showed a reduction in the time spent in hyperglycemia, an increase in time
hypoglycemia 14749 hypoglycemic episodes during the use of the sensor. Clinical benefits of FGM use, in particular a reduction in hypoglycemia , have also been reported in patients with type 2 diabetes mellitus (T2DM) on intensive insulin therapy
hypoglycemia 17975 some advantages over FGM, such as better accuracy in the newest models of sensors, alarms in case of hypoglycemia or hyperglycemia and the possibility to connect to an insulin pump. For example, for individuals with
hypoglycemia 18097 hyperglycemia and the possibility to connect to an insulin pump. For example, for individuals with severe hypoglycemia unawareness, iCGM associated with predictive or low-threshold glucose insulin-suspended technology might
hypoglycemia 20017 be greater than 10%. With regard to the effect of FGM on metabolic control, this device could reduce hypoglycemia in both the T1DM and T2DM [[6],[24],[25],[26]]. Moreover, some studies have shown a reduction in glycemic
hypoglycemia 20449 research should investigate the effect of this type of sensor on glycemic control and the frequency of hypoglycemia in pediatric patients with T1DM, as there are no current studies specific to the pediatric population
type 1 diabetes mellitus 719 giulia.cec@hotmail.it (G.C.)Publication date (epub): 7/2018Publication date (collection): 8/2018AbstractIn people with type 1 diabetes mellitus (T1DM), obtaining good glycemic control is essential to reduce the risk of acute and chronic complications.
type 1 diabetes mellitus 2867 lead to long-term microvascular and macrovascular complications [[1],[2]]. Therefore, in people with type 1 diabetes mellitus (T1DM), obtaining good glycemic control is essential to reduce the risk of acute and chronic complications
type 2 diabetes mellitus 14804 benefits of FGM use, in particular a reduction in hypoglycemia, have also been reported in patients with type 2 diabetes mellitus (T2DM) on intensive insulin therapy [[25],[26]]. Other authors [[27],[28]] showed improved metabolic

You must be authorized to submit a review.